These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21555624)

  • 21. Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Teraki Y; Kawabe M; Izaki S
    J Allergy Clin Immunol; 2013 Mar; 131(3):907-9. PubMed ID: 23083672
    [No Abstract]   [Full Text] [Related]  

  • 22. [Stevens-Johnson syndrome in the dentist practice].
    Kazankova EM; Tirskaya OI
    Stomatologiia (Mosk); 2016; 95(5):51-52. PubMed ID: 27876724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Williams PM; Conklin RJ
    Dent Clin North Am; 2005 Jan; 49(1):67-76, viii. PubMed ID: 15567361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Sanclemente G; De la Roche CA; Escobar CE; Falabella R
    Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H
    J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma.
    Ikeda M; Fujita T; Amoh Y; Mii S; Matsumoto K; Iwamura M
    Urol Int; 2013; 91(4):482-3. PubMed ID: 23969404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic epidermal necrolysis-like lesions as a manifestation of lupus erythematosus: the clinical picture of two cases.
    Rubio-González B; Angulo-Martínez L; Vanaclocha-Sebastián F; Postigo-Llorente C; Llamas-Martín R
    Arthritis Rheumatol; 2014 Jun; 66(6):1607. PubMed ID: 24577870
    [No Abstract]   [Full Text] [Related]  

  • 31. Short root anomaly in a patient with a history of Stevens-Johnson syndrome: report of case.
    Thornton JB; Worley SL
    ASDC J Dent Child; 1991; 58(3):256-9. PubMed ID: 2066480
    [No Abstract]   [Full Text] [Related]  

  • 32. A potential new sign in patients with toxic epidermal necrolysis.
    Lipový B
    Burns; 2016 Nov; 42(7):1618-1620. PubMed ID: 27576928
    [No Abstract]   [Full Text] [Related]  

  • 33. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stevens-Johnson syndrome with exclusive mucosal involvement].
    Caballero Doménech JC; Pou M; Lima J; Fernández Cortijo J; Herrero E
    Aten Primaria; 1989 Mar; 6(3):199-200. PubMed ID: 2518922
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE; Trent JT; Kerdel FA
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Odinophagia and cutaneous lesions in patient with cerebral metastases].
    García Sánchez I; Chavarria Mur E; Avilés Izquierdo J; Molina Sánchez-Cabezudo F; Vera López E; Gilsanz Fernández C
    Rev Clin Esp; 2006 May; 206(5):251-3. PubMed ID: 16750112
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.
    Shammas MC; Lai EC; Sarkar JS; Yang J; Starr CE; Sippel KC
    Am J Ophthalmol; 2010 Feb; 149(2):203-213.e2. PubMed ID: 20005508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: immunohistochemical comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M; Torchia D; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Fabbri P
    Br J Dermatol; 2008 May; 158(5):1163-6. PubMed ID: 18363765
    [No Abstract]   [Full Text] [Related]  

  • 39. Amniotic membrane grafting in the management of acute toxic epidermal necrolysis/Stevens Johnson syndrome.
    Warkad VU; Sahu SK; Das S
    Am J Ophthalmol; 2011 Feb; 151(2):381-2; author reply 382. PubMed ID: 21251496
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.